Macrophage migration inhibitory factor (MIF): A promising biomarker
- 1 January 2010
- journal article
- review article
- Published by Portico in Drug News & Perspectives
- Vol. 23 (4), 257-64
- https://doi.org/10.1358/dnp.2010.23.4.1453629
Abstract
Macrophage migration inhibitory factor (MIF) is an immunoregulatory cytokine, the effect of which on arresting random immune cell movement was recognized several decades ago. Despite its historic name, MIF also has a direct chemokine-like function and promotes cell recruitment. Multiple clinical studies have indicated the utility of MIF as a biomarker for different diseases that have an inflammatory component; these include systemic infections and sepsis, autoimmune diseases, cancer, and metabolic disorders such as type 2 diabetes and obesity. The identification of functional promoter polymorphisms in the MIF gene (MIF) and their association with the susceptibility or severity of different diseases has not only served to validate MIF's role in disease development but also opened the possibility of using MIF genotype information to better predict risk and outcome. In this article, we review the clinical data of MIF and discuss its potential as a biomarker for different disease applications.Keywords
This publication has 100 references indexed in Scilit:
- Do serum biomarkers really measure breast cancer?BMC Cancer, 2009
- MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic DiseaseCirculation Research, 2009
- Development and Validation of a Protein-based Signature for the Detection of Ovarian CancerClinics in Laboratory Medicine, 2009
- Serum Macrophage Migration Inhibitory Factor Is an Early Marker of Pancreatic Necrosis in Acute PancreatitisAnnals of Surgery, 2007
- Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective studyCritical Care, 2007
- Amplification of Tumor Hypoxic Responses by Macrophage Migration Inhibitory Factor–Dependent Hypoxia-Inducible Factor StabilizationCancer Research, 2007
- A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemiaThe Journal of Experimental Medicine, 2006
- Inflamed fat: what starts the fire?JCI Insight, 2005
- Inflammation and cancerNature, 2002
- The Hallmarks of CancerCell, 2000